期刊文献+

临床分离酵母菌55株体外药敏试验分析 被引量:6

Analysis of the Drug Aenaitivity test in Vitro on Clinical Isolated Pathogenic Yeast
下载PDF
导出
摘要 目的了解酮康唑、萘替芬、特比萘芬及酮康唑、萘替芬联合应用对55株临床分离致病酵母菌株的体外抗真菌活性。方法采用标准微量稀释法测定上述三种抗真菌药及联合用药对55株临床分离致病酵母菌的最低抑菌浓度(M IC)。结果酮康唑、萘替芬、特比萘芬及酮康唑、萘替芬联合应用的M IC均值分别为0.281855μg/m l,1.528111μg/m l,1.000443μg/m l,0.199125μg/m l。结论联合用药的疗效优于单用酮康唑、萘替芬、特比萘芬(P<0.05)。
出处 《中国皮肤性病学杂志》 CAS 北大核心 2005年第8期475-477,共3页 The Chinese Journal of Dermatovenereology
  • 相关文献

参考文献5

  • 1王文莉,郑玮清,李若瑜,王端礼,万哲,王晓红.采用NCCLS M27-A方案微量法检测念珠菌对抗真菌药物的敏感性[J].中华检验医学杂志,2001,24(2):107-108. 被引量:40
  • 2Barchiesi F, Schimizzi AM, Najvar K, et al. Interactions of posaconazole and flucytosine against cryptococcus neoformans [ J ]. Antimicrobial Agents and Chemotherapy, 2001, (5): 1355 -1359. 被引量:1
  • 3Barchiesi F, Falconi Di, Francescol, et al. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of candida albicans with reduced susceptibility to azoles [ J ]. Antimicrob Agents Chemother, 1997,41 ( 8 ): 1812 - 1814. 被引量:1
  • 4Hong MN, Francesco B, Deanna A,et al. In vitro Evaluation of Combination of Fluconazole and Flucytosine against Cryptococcus neoformans var. neoformans [ J ]. Antimicrobia Agents And Chemotherapy, 1995,39(8) :1691 - 1695. 被引量:1
  • 5Gupta AK, KohliY. In vitro susceptibility testing of ciclopirox, terbinaifine ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evalution of combination antifungal activity [ J ].BJ-Dermatol, 2003,149 ( 2 ): 296 - 305. 被引量:1

二级参考文献4

共引文献39

同被引文献63

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部